US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

8.4% Sodium Bicarbonate Injection

Reason Lack of Assurance of Sterility

Exela Pharma Sciences LLC NDC 51754-5001-1 D-0369-2022
Class II · Moderate risk Terminated

Tretinoin Capsules

Reason Failed Dissolution Specifications; Low Out of specification (OOS) results for dissolution.

Teva Pharmaceuticals USA NDC 0555-0808-02 D-0520-2022
Class II · Moderate risk Terminated

Clobetasol Propionate Foam

Reason CGMP Deviations

Ingenus Pharmaceuticals Llc NDC 50742-304-50 D-0374-2022
Class II · Moderate risk Terminated

Clobazam Oral Suspension 2.5 mg/mL

Reason Failed Stability Specifications

VistaPharm, Inc. NDC 66689-058-04 D-0376-2022
Class II · Moderate risk Terminated

Sufentanil Citrate Injection

Reason Subpotent Drug: Out of specification for assay at the 30-month stability timepoint.

Akorn, Inc. NDC 17478-0050-02 D-0460-2022
Class II · Moderate risk Terminated

Metoprolol Tartrate Tablets

Reason Complaint received of foreign matter (metal) embedded in tablet.

Rubicon Research Private Limited NDC 52817-360-00 D-0362-2022
Class II · Moderate risk Terminated

Metformin 750 mg Extended Release NDC # 70518-2920-00

Reason CGMP Deviations: Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

RemedyRepack Inc. NDC 70518-2920-00 D-0366-2022
Class II · Moderate risk Terminated

Pioglitazone Tablets USP

Reason Superpotent and Failed Tablet/Capsule Specifications

Aurobindo Pharma USA Inc. NDC 57237-221-05 D-0450-2022
Class II · Moderate risk Terminated

Cefixime 400 mg capsule

Reason Failed Impurities/Degradation Specifications

RemedyRepack Inc. NDC 70518-2749-02 D-0360-2022
Class II · Moderate risk Terminated

Metformin Hydrochloride Extended-Release Tablets

Reason CGMP Deviations- Detection of N-Nitrosodimethylamine (NDMA) levels in excess of the Acceptable Daily Intake Limit.

Viona Pharmaceuticals INC NDC 72578-036-01 D-0392-2022
Class II · Moderate risk Terminated

Nitroglycerin Lingual Spray

Reason Defective Delivery System

Padagis US LLC NDC 45802-210-02 D-0372-2022
Class II · Moderate risk Terminated

Cefixime Capsules

Reason Failed impurities/degradation specifications

Ascend Laboratories, LLC NDC 67877-584-50 D-0359-2022
Class II · Moderate risk Terminated

Brinzolamide Ophthalmic Suspension

Reason Defective Container: The notch in the cap that fits into the nozzle of the dropper could break off and block the dropper possibly resulting in the product not dispensing.

Teva Pharmaceuticals USA NDC 0591-2127-79 D-0373-2022
Class II · Moderate risk Terminated

Trypan Blue 0.03%

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1348-01 D-0449-2022
Class II · Moderate risk Terminated

Vancomycin HCl Oral Solution

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1348-01 D-0448-2022
Class II · Moderate risk Terminated

Tetracaine HCl Nasal Solution

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1195-03 D-0447-2022
Class II · Moderate risk Terminated

Vitamin K

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1132-03 D-0445-2022
Class II · Moderate risk Terminated

Phenol

Reason CGMP Deviations

Edge Pharma, LLC NDC 05446-1211-03 D-0443-2022